Across TCGA pan-cancer cohorts, RPSAP19 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPSAP19’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where RPSAP19 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPSAP19 is over-expressed in tumor.

LIHC and KIRP are the cancer types where RPSAP19 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPSAP19 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	II,III,IV	+0.803	<.001	7	view →
KIRP	All	IV	+1.014	.002	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RPSAP19 RNA expression & survival · all RPSAP19 data types